Determining the correct retatrutide amount is critically important for obtaining desired benefits. Initially, patients typically start with a introductory quantity of around 2.4 mg, given once week via subcutaneous . This initial dose is then incrementally increased every four periods, until a peak quantity of 10.8 mg, depending on person reaction